Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 6Unknown 3Terminated 2Active not recruiting 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 49Thoracic 42Other hematologic neoplasm 35Sarcoma 13CNS 10Plasma cell 9Myeloid 5Genitourinary 5Dermatologic 5Other solid neoplasm 4Gynecologic 4Classical hematology 4Head & Neck 3Breast 3Gastrointestinal 2Tumor-Agnostic 1

Conditions

Carcinoma, Hepatocellular 2Wilms Tumor 1Sarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Medulloblastoma 1Liver Neoplasms 1Kidney Neoplasms 1Hepatoblastoma 1Familial ependymoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Astrocytoma 1

Interventions

Fluorouracil 145Gemcitabine 141Oxaliplatin 135Capecitabine 133Leucovorin 107Irinotecan 99Bevacizumab 92Cetuximab 68Cisplatin 67pembrolizumab 61Radiotherapy 60Nivolumab 41130-nm albumin-bound paclitaxel 41Sorafenib 39Docetaxel 34Albumin-Bound Paclitaxel 31Radiosurgery 28Paclitaxel 27Surgical Procedures, Operative 25regorafenib 24Erlotinib Hydrochloride 23Panitumumab 22Cyclophosphamide 21Celecoxib 20Trastuzumab 19Radiation 18Neoadjuvant Therapy 18IFL protocol 18atezolizumab 17Carboplatin 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Etoposide × Gastrointestinal × Clear all
NCT00623077 2017-12-05

MT2004-30: Tomotherapy for Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
23 enrolled
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Familial ependymoma, Astrocytoma, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Retinoblastoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor, Optic Nerve Glioma

NCT00351195 2008-08-26

Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC)

Rigshospitalet, Denmark

Phase 2 Terminated
39 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡